Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Net Income (2023 - 2025)

Historic Net Income for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$8.8 million.

  • Onconetix's Net Income fell 12949.5% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.1 million, marking a year-over-year increase of 479.69%. This contributed to the annual value of -$58.7 million for FY2024, which is 5688.72% down from last year.
  • Onconetix's Net Income amounted to -$8.8 million in Q3 2025, which was down 12949.5% from -$2.4 million recorded in Q2 2025.
  • Over the past 5 years, Onconetix's Net Income peaked at -$2.4 million during Q2 2025, and registered a low of -$29.4 million during Q4 2024.
  • In the last 3 years, Onconetix's Net Income had a median value of -$8.5 million in 2025 and averaged -$10.5 million.
  • Per our database at Business Quant, Onconetix's Net Income plummeted by 29058.53% in 2024 and then surged by 8341.75% in 2025.
  • Over the past 3 years, Onconetix's Net Income (Quarter) stood at -$22.4 million in 2023, then crashed by 31.64% to -$29.4 million in 2024, then skyrocketed by 70.16% to -$8.8 million in 2025.
  • Its Net Income stands at -$8.8 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$8.5 million for Q1 2025.